59 related articles for article (PubMed ID: 8531224)
1. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain.
Weeks BS; Lieberman DM; Johnson B; Roque E; Green M; Loewenstein P; Oldfield EH; Kleinman HK
J Neurosci Res; 1995 Sep; 42(1):34-40. PubMed ID: 8531224
[TBL] [Abstract][Full Text] [Related]
2. Tat mediates apoptosis in vivo in the rat central nervous system.
Gavriil ES; Cooney R; Weeks BS
Biochem Biophys Res Commun; 2000 Jan; 267(1):252-6. PubMed ID: 10623606
[TBL] [Abstract][Full Text] [Related]
3. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload.
Hui B; Li J; Geng MY
J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356
[TBL] [Abstract][Full Text] [Related]
4. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.
Liu Y; Jones M; Hingtgen CM; Bu G; Laribee N; Tanzi RE; Moir RD; Nath A; He JJ
Nat Med; 2000 Dec; 6(12):1380-7. PubMed ID: 11100124
[TBL] [Abstract][Full Text] [Related]
5. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
6. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.
Hui B; Xia W; Li J; Wang L; Ai J; Geng M
J Neurochem; 2006 Apr; 97(2):334-44. PubMed ID: 16539678
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
9. HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation.
Bergonzini V; Delbue S; Wang JY; Reiss K; Prisco M; Amini S; Khalili K; Peruzzi F
Oncogene; 2004 Oct; 23(46):7701-11. PubMed ID: 15361847
[TBL] [Abstract][Full Text] [Related]
10. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
11. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.
Nath A; Haughey NJ; Jones M; Anderson C; Bell JE; Geiger JD
Ann Neurol; 2000 Feb; 47(2):186-94. PubMed ID: 10665489
[TBL] [Abstract][Full Text] [Related]
12. [Effects of human immunodeficiency virus type 1 nef and tat genes on rat PC12 pheochromocytoma cells].
Shugurova IM; Bobrysheva IV; Grivennikov IA; Tarantul VZ
Genetika; 2000 Aug; 36(8):1140-6. PubMed ID: 11033786
[TBL] [Abstract][Full Text] [Related]
13. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.
Theodore S; Cass WA; Maragos WF
Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141
[TBL] [Abstract][Full Text] [Related]
14. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.
Mishra M; Vetrivel S; Siddappa NB; Ranga U; Seth P
Ann Neurol; 2008 Mar; 63(3):366-76. PubMed ID: 18074388
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction.
Theodore S; Cass WA; Nath A; Steiner J; Young K; Maragos WF
Neurobiol Dis; 2006 Sep; 23(3):663-8. PubMed ID: 16828290
[TBL] [Abstract][Full Text] [Related]
16. Influence of the human immunodeficiency virus type 1 Tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells.
Milani D; Zauli G; Neri LM; Marchisio M; Previati M; Capitani S
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2587-94. PubMed ID: 8277265
[TBL] [Abstract][Full Text] [Related]
17. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.
Liu ZQ; Muhkerjee S; Sahni M; McCormick-Davis C; Leung K; Li Z; Gattone VH; Tian C; Doms RW; Hoffman TL; Raghavan R; Narayan O; Stephens EB
Virology; 1999 Aug; 260(2):295-307. PubMed ID: 10417264
[TBL] [Abstract][Full Text] [Related]
18. The neuropathology of adult HIV infection.
Bell JE
Rev Neurol (Paris); 1998 Dec; 154(12):816-29. PubMed ID: 9932303
[TBL] [Abstract][Full Text] [Related]
19. Acute in vivo neurotoxicity of peptides from Maedi Visna virus transactivating protein Tat.
Starling I; Wright A; Arbuthnott G; Harkiss G
Brain Res; 1999 Jun; 830(2):285-91. PubMed ID: 10366685
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the influsion speed and acute toxicity of amino acid solutions in rats (author's transl)].
Fukuda T; Kataoka M; Yamaguchi A; Tanizawa H
Nihon Yakurigaku Zasshi; 1978 Jul; 74(5):589-95. PubMed ID: 700520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
